IR
Opus Genetics, Inc. (IRD)
NASDAQ·Healthcare·Biotechnology
$5.00
-2.34%
Mkt Cap $373.44M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 10, 2026 | $3.20M | — | — | -$0.11 | -$0.14 | -27.27% | — | — |
| Q4 2025 Nov 12, 2025 | $3.07M | $3.08M | +0.25% | -$0.14 | -$0.12 | +14.29% | — | — |
| Q3 2025 Aug 13, 2025 | $3.08M | $2.88M | -6.53% | -$0.25 | -$0.12 | +52.00% | — | — |
| Q2 2025 May 15, 2025 | $3.40M | $4.37M | +28.53% | -$0.34 | -$0.32 | +5.88% | — | — |
| Q1 2025 Mar 31, 2025 | $3.39M | $4.30M | +26.96% | -$0.34 | -$1.27 | -273.53% | — | — |
| Q4 2024 Nov 12, 2024 | $11.10M | $3.87M | -65.18% | -$0.30 | -$0.29 | +3.33% | — | — |
| Q3 2024 Aug 13, 2024 | $2.45M | $1.11M | -54.67% | -$0.25 | -$0.30 | -20.00% | — | — |
| Q2 2024 May 10, 2024 | $5.34M | $1.71M | -67.96% | -$0.18 | -$0.29 | -61.11% | — | — |
| Q1 2024 Mar 9, 2024 | $5.36M | $1.69M | -68.43% | -$0.05 | -$0.22 | -315.20% | — | — |
| Q4 2023 Nov 13, 2023 | $3.03M | $11.94M | +294.52% | -$0.22 | $0.25 | +211.80% | — | — |
| Q2 2023 Jun 30, 2023 | $2.43M | $3.67M | +51.50% | -$0.23 | -$0.24 | -4.73% | — | — |
| Q1 2023 Mar 31, 2023 | $2.95M | $1.75M | -40.74% | -$0.15 | -$0.28 | -79.58% | — | — |
| Q4 2022 Dec 31, 2022 | — | $39.85M | — | — | $1.58 | — | — | — |
| Q3 2022 Sep 30, 2022 | — | — | — | -$0.28 | -$0.22 | +21.62% | — | — |
| Q2 2022 Jun 30, 2022 | — | — | — | — | -$0.25 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$0.35 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$0.35 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | $489.00K | — | — | -$0.25 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | $100.00K | — | — | -$0.52 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$3.57 | — | — | — |